Curocell's CAR-T Drug Limcato Publishes Trial Results in Blood Journal

Curocell has published new clinical trial results. The findings concern the CAR-T drug known as Limcato. The research was published in the Blood journal. Limcato is a key focus of the reported study. The publication provides data on the drug's performance. This development is significant for the field of therapeutics. The results offer insights into the efficacy of the treatment. Medical professionals will now review the published data.